ID   ABC09
AC   CVCL_C8LM
DR   Wikidata; Q123030387
RX   Patent=CN111454912B;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, China General Microbiological Culture Collection Center; CGMCC No.19162.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: ChEBI; CHEBI:92386; Xylazine.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_2199 ! Sp2/0-Ag14
CA   Hybridoma
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
RX   Patent=CN111454912B;
RA   Xu C.-L., Chao M.-J., Kuang H., Xu L.-G., Sun M.-Z., Liu L.-Q.,
RA   Wu X.-L., Song S.-S., Hu Y.-M., Hao C.-L.;
RT   "A xylazine monoclonal antibody hybridoma cell line and application
RT   thereof.";
RL   Patent number CN111454912B, 29-Oct-2021.
//